P&G Philippines, in consultation with the Philippine Food and Drug Administration (FDA), has initiated a voluntary recall of Sangobion Kids 100 ml iron + Vitamin B-Complex in the Philippines.
Sangobion Kids 100 ml is indicated for the treatment and prevention of iron deficiency anemia (IDA) in children, latent insufficiency of iron and vitamin B during the growth period, and iron deficiency after loss of blood. It is also used as a supplement during conditions of chronic illnesses and during convalescence.
The voluntary recall is limited to Sangobion Kids 100 ml sold in the Philippines, P&G Philippines said. Sangobion Kids sold in other countries were not affected by the recall. No other Sangobion product sold in the Philippines or other countries were affected, the P&G Philippines said.
Upon learning of the potential presence of ethylene glycol above the allowable limits in raw material, P&G Philippines said it decided to take precautionary measures including the voluntary recall of all batches of Sangobion Kids 100 ml.
“Though the issue only impacted some batches, we are recalling all batches out of an abundance of caution,” it said in a press release.
“Nothing is more important to us than the safety of our consumers and the quality of our products. The potential presence of ethylene glycol in the product may result in adverse drug reactions. That is why even though our inspections and tests are still ongoing, we have decided to proactively recall all batches still in circulation to ensure our consumers only get products that meet P&G’s quality promise,” it added.
P&G Philippines advised those who had purchased Sangobion Kids 100 ml in the Philippines to discontinue using the product. Consumers may contact P&G Consumer Care at https://sangobion.com.ph/contactus.
Retailers and pharmacies were also requested to stop the distribution, sale and use of the product and contact their authorized distributor’s representatives for the return of remaining stocks. Healthcare professionals were also requested to stop distributing sales samples and return remaining stocks to P&G sales representatives.
Children who have consumed the product and experienced adverse reactions including vomiting, diarrhea, abdominal pain, headache, altered mental state, symptoms of acute kidney injury like inability to pass or reduced urine, lower back pain, or additional symptoms of irritability, lethargy, pale appearance, decreased muscle tone, and loss of appetite in younger kids, were advised to contact the National Poison Management and Control Center at (02) 8524 1078 and seek urgent medical attention and report to the FDA or P&G Consumer Care.
